|
|||||
|
|
Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti‐obesity drugs |
|
| Authors: | Marjolein J. C. Willemen PharmD Aukje K. Mantel‐Teeuwisse PhD Sabine M. J. M. Straus PhD Hubert G. M. Leufkens PhD Antoine C. G. Egberts PhD Miriam C. J. M. Sturkenboom PhD |
| Affiliation: | 1. Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, the Netherlands;2. Medicines Evaluation Board, The Hague, the Netherlands;3. Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, the Netherlands;4. Departments of Medical Informatics and Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands |
| Abstract: | |
| Keywords: | obesity medicines pharmacovigilance benefit‐risk assessment |